Merola, Joseph, Curdin Conrad, Peter Foley, Lars Iversen, Richard Langley, Georgios Kokolakis, Leah Davis, Bengt Hoepken, Joe Dixon, and Richard Warren. 2024. “Bimekizumab Versus Secukinumab Continuous Maintenance of PASI 90 and PASI 100 Responses through One Year in Patients With Moderate to Severe Plaque Psoriasis: Post-HOC Results from the BE RADIANT Phase 3b Trial”. SKIN The Journal of Cutaneous Medicine 8 (2):s403. https://doi.org/10.25251/skin.8.supp.403.